Increasing Very Low-Dose Edoxaban Prescription: Effectiveness and Safety Data of Korean AF Patients
Article 2024 en
Authors
JC
JungMin Choi
SY
S K Yang
SL
So-Ryoung Lee
Abstract
1 min read
The prescription of very low-dose edoxaban was increased over time, attributable to various clinical factors. The use of very low-dose edoxaban reduced the expected risk of thromboembolic events.
Discussion(0)
No comments yet. Be the first to comment.